晟德(two:4123)center Ventures

Center Ventures started with pharmaceutical business in 1957. Now we are the most professional biotech corporate venture capital (CVC) in Taiwan, with nearly 1B USD in AUM. Our main investment strategy is as follows: 1. Focus on selection: We will continue to leverage our advantages in the medical and health fields, combine innovative technology and trends, and seize future opportunities; at the same time, we will expand upstream and downstream, increase economies of scale, and cover manufacturing, channels and services. Asset management: We continue to optimize our investment portfolio, expand our investment benefits, and assist our invested companies in adjusting their strategies. While pursuing high growth of enterprises, we strive to achieve a balance between innovation, stability and high liquidity. Resource integration: We will operate our invested companies in a group manner, integrate international resources, and share experience, knowledge and talent.